Literature DB >> 1138546

Mitral valve disease of systemic lupus erythematosus. A cause of severe congestive heart failure reversed by valve replacement.

S A Paget, B H Bulkley, L E Grauer, R Seningen.   

Abstract

Libman-Sacks endocarditis caused progressive life-threatening mitral regurgitation necessitating mitral valve replacement in an 18 year old woman with systemic lupus erythematosus (SLE). Although Libman-Sacks endocarditis is frequently seen at autopsy in patients with SLE, hemodynamically significant valvular disease due to that lesion is quite rare. We found no previous reports describing mitral regurgitation in a patient with SLE which has necessitated surgical intervention.

Entities:  

Mesh：

Year:  1975        PMID： 1138546     DOI： 10.1016/0002-9343(75)90331-9

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


  11 in total

1.  Infective endocarditis, rheumatoid factor, and anticardiolipin antibodies.

Authors:  R A Asherson; M Tikly; H Staub; P T Wilmshurst; D J Coltart; M Khamashta; G R Hughes
Journal:  Ann Rheum Dis       Date:  1990-02       Impact factor: 19.103

2.  Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus.

Authors:  D Logar; T Kveder; B Rozman; J Dobovisek
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

3.  Valve replacement for severe tricuspid regurgitation caused by Libman-Sacks endocarditis.

Authors:  J Laufer; M Frand; S Milo
Journal:  Br Heart J       Date:  1982-09

4.  Right ventricular diastolic dysfunction in patients with anticardiolipin antibodies and antiphospholipid syndrome.

Authors:  M G Tektonidou; J P Ioannidis; I Moyssakis; K A Boki; V Vassiliou; P G Vlachoyiannopoulos; M K Kyriakidis; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

Review 5.  Mitral valve surgery for mitral regurgitation caused by Libman-Sacks endocarditis: a report of four cases and a systematic review of the literature.

Authors:  Wobbe Bouma; Theo J Klinkenberg; Iwan C C van der Horst; Inez J Wijdh-den Hamer; Michiel E Erasmus; Marc Bijl; Albert J H Suurmeijer; Felix Zijlstra; Massimo A Mariani
Journal:  J Cardiothorac Surg       Date:  2010-03-23       Impact factor: 1.637

6.  Mitral regurgitation due to lupus endocarditis treated with valve replacement.

Authors:  F J Brennan; S E Ford; P M Ford; P A Morrin; G W Burggraf; T A Salerno
Journal:  Can Med Assoc J       Date:  1983-09-15       Impact factor: 8.262

7.  Immunopathogenesis of Libman-Sacks endocarditis. Assessment by light and immunofluorescent microscopy in two patients.

Authors:  R F Shapiro; C N Gamble; K B Wiesner; J J Castles; A W Wolf; E J Hurley; A F Salel
Journal:  Ann Rheum Dis       Date:  1977-12       Impact factor: 19.103

8.  [Systemic lupus erythematosus and congestive heart failure. Heart histological and ultrastructural study (author's transl)].

Authors:  P Walter; M Weill-Bousson; J M Mossart; R Voegtlin
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-08-09

9.  Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions, and transient ischaemic attacks.

Authors:  R A Asherson; D G Gibson; D W Evans; E Baguley; G R Hughes
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

10.  Mitral valve replacement for mitral stenosis caused by Libman-Sacks endocarditis.

Authors:  K C Vaughton; D R Walker; M F Sturridge
Journal:  Br Heart J       Date:  1979-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.